SCHEMBL24360873

SCHEMBL24360873

COC(=O)c1ccccc1OC(=O)C(F)(F)C(F)(F)C(F)(F)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 3/20 0.56
▸ KMT2A Q03164 3/20 0.47
▸ HTT P42858 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ SLC6A4 P31645 1/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ ELANE P08246 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ PRSS1 P07477 1/20 0.43
▸ ACR P10323 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ ATM Q13315 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PDK2 Q15119 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CFTR P13569 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24361102 0.92 SLC6A3 (0.59) SLC6A3KMT2AHTTMAPTSLC6A4
SCHEMBL24360877 0.86 ELANE (0.46) SLC6A3KMT2AHTTMAPTHSD17B10
SCHEMBL24360869 0.83 KDM4E (0.40) SLC6A3KMT2AHTTHSD17B10ELANE
SCHEMBL24360786 0.78 ELANE (0.48) SLC6A3KMT2AHTTMAPTHSD17B10
SCHEMBL3932901 0.75 SLC6A3 (0.74) SLC6A3KMT2AHTTMAPTSLC6A4
SCHEMBL24361015 0.74 ALDH1A1 (0.54) SLC6A3KMT2AHTTMAPTHSD17B10
SCHEMBL24361101 0.74 KDM4E (0.41) SLC6A3KMT2AHTTMAPTHSD17B10
SCHEMBL19432834 0.74 ELANE (0.42) MAPTHSD17B10ELANEKDM4EHPGD
SCHEMBL25788263 0.74 KDM4E (0.51) KMT2AHTTMAPTHSD17B10ELANE
SCHEMBL5706028 0.73 SLC6A3 (0.77) SLC6A3KMT2AHTTMAPTSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127225-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127225-A1 ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS CACNA1F, SLC6A5, IDUA SLC6A3 793/4885KMT2A 2537/4885HTT 3870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback